Antibiotic Treatment Guidelines
Introduction to Ceftolozane/Tazobactam
- The recommended dose of ceftolozane/tazobactam for adults with normal renal function is 1.5 g (1 g ceftolozane/0.5 g tazobactam) administered intravenously every 8 hours, as recommended by the World Journal of Emergency Surgery and the Journal of Microbiology, Immunology and Infection 1, 2
Dosage Recommendations
- For complicated urinary tract infections and complicated intra-abdominal infections, the recommended dose is 1.5 g (1 g ceftolozane/0.5 g tazobactam) IV every 8 hours, with a duration of 5-10 days, according to the Journal of Microbiology, Immunology and Infection 2
- For nosocomial pneumonia (hospital-acquired or ventilator-associated), the recommended dose is 3 g (2 g ceftolozane/1 g tazobactam) IV every 8 hours, with a duration of 10-14 days, as recommended by the Journal of Microbiology, Immunology and Infection 2
Dose Adjustment Based on Renal Function
| Creatinine Clearance (CrCl) | Recommended Dose |
|---|---|
| >50 mL/min | 1.5 g every 8 hours |
| 30-50 mL/min | 750 mg every 8 hours |
| 15-29 mL/min | 375 mg every 8 hours |
- Ceftolozane/tazobactam requires dose adjustment based on renal function, with specific recommendations for patients with varying levels of creatinine clearance, as outlined in the Journal of Microbiology, Immunology and Infection 2
Effective Use and Combination Therapy
- Ceftolozane/tazobactam is particularly effective against multidrug-resistant Pseudomonas aeruginosa, including carbapenem-resistant strains, according to the Journal of Microbiology, Immunology and Infection 2
- It can be used as a carbapenem-sparing regimen in critically ill patients with healthcare-associated infections, as recommended by the World Journal of Emergency Surgery 1
- For intra-abdominal infections, combination with metronidazole (500 mg IV every 6 hours) is recommended for anaerobic coverage, as suggested by the World Journal of Emergency Surgery 1